Atlas Venture

Atlas Venture is a leading early-stage venture capital firm based in Cambridge, Massachusetts, specializing in the creation and development of biotech companies. The firm partners with scientific entrepreneurs to translate breakthrough innovations into new therapeutic solutions that address unmet medical needs. By combining deep domain expertise with an entrepreneurial approach, Atlas plays a hands-on role in company formation and growth.

Since its founding, Atlas has been instrumental in launching and scaling numerous successful biotechnology startups. The firm provides more than capital—it contributes operational guidance, strategic support, and access to a robust network of advisors, co-investors, and industry leaders. This integrated approach has made Atlas a key player in the biotech ecosystem.

Atlas Venture maintains a sharp focus on early-stage investing, often co-founding companies from the ground up. Its portfolio includes a broad range of therapeutic areas including oncology, immunology, neurology, and rare diseases. With its base in the biotech hub of Cambridge, the firm is well-positioned to harness cutting-edge research and talent to fuel innovation globally.